TY - JOUR
T1 - Significant Differences in IBD Care and Education across Europe
T2 - Results of the Pan-European VIPER Survey
AU - Kral, Jan
AU - Nakov, Radislav
AU - Lanska, Vera
AU - Barberio, Brigida
AU - Benech, Nicolas
AU - Blesl, Andreas
AU - Brunet, Eduard
AU - Capela, Tiago
AU - Derikx, Lauranne
AU - Dragoni, Gabriele
AU - Eek, Aileen
AU - Frias-Gomes, Catarina
AU - Gîlcǎ-Blanariu, Georgiana Emmanuela
AU - Gilroy, Leah
AU - Harvey, Philip
AU - Kagramanova, Anna
AU - Kani, Haluk Tarik
AU - Konikoff, Tom
AU - Lessing, Matthias
AU - Madsen, Gorm
AU - Maksimaityte, Vaidota
AU - Miasnikova, Maria
AU - Mikolasevic, Ivana
AU - Milivojevic, Vladimir
AU - Noviello, Daniele
AU - Oliinyk, Dmytro
AU - Patai, Arpad
AU - Pisani, Anthea
AU - Protopapas, Adonis
AU - Rodríguez-Lago, Iago
AU - Schreiner, Philipp
AU - Skuja, Vita
AU - Tran, Florian
AU - Truyens, Marie
AU - Włodarczyk, Marcin
AU - Zatorski, Hubert
AU - Verstockt, Bram
AU - Segal, Jonathan Philip
N1 - Publisher Copyright:
© 2022 S. Karger AG, Basel.
PY - 2023/5/1
Y1 - 2023/5/1
N2 - BACKGROUND: Inflammatory bowel disease (IBD) care and education might differ around Europe. Therefore, we conducted this European Variation In IBD PracticE suRvey (VIPER) to investigate potential differences between countries.METHODS: This trainee-initiated survey, run through SurveyMonkey®, consisted of 47 questions inquiring basic demographics, IBD training, and clinical care. Results were compared according to gross domestic product (GDP) per capita, for which countries were divided into 2 groups (low/high income, according to the World Bank).RESULTS: The online survey was completed by 1,285 participants from 40 European countries, with a majority of specialists (65.3%) working in academic institutions (50.4%). Significant differences in IBD-specific training (55.9% vs. 38.4%), as well as availability of IBD units (58.4% vs. 39.7%) and multidisciplinary meetings (73.2% vs. 40.1%), were observed between respondees from high and low GDP countries (p < 0.0001). In high GDP countries, IBD nurses are more common (85.9% vs. 36.0%), also mirrored by more nurse-led IBD clinics (40.6% vs. 13.7%; p < 0.0001). IBD dieticians (33.4% vs. 16.5%) and psychologists (16.8% vs. 7.5%) are mainly present in high GDP countries (p < 0.0001). In the current COVID era, telemedicine is available in 73.2% versus 54.1% of the high/low GDP countries, respectively (p < 0.0001). Treat-to-target approaches are implemented everywhere (85.0%), though access to biologicals and small molecules differs significantly.CONCLUSION: Much variability in IBD practice exists across Europe, with marked differences between high and low GDP countries. Further work is required to help address some of these inequalities, aiming to improve and standardize IBD care and training across Europe.
AB - BACKGROUND: Inflammatory bowel disease (IBD) care and education might differ around Europe. Therefore, we conducted this European Variation In IBD PracticE suRvey (VIPER) to investigate potential differences between countries.METHODS: This trainee-initiated survey, run through SurveyMonkey®, consisted of 47 questions inquiring basic demographics, IBD training, and clinical care. Results were compared according to gross domestic product (GDP) per capita, for which countries were divided into 2 groups (low/high income, according to the World Bank).RESULTS: The online survey was completed by 1,285 participants from 40 European countries, with a majority of specialists (65.3%) working in academic institutions (50.4%). Significant differences in IBD-specific training (55.9% vs. 38.4%), as well as availability of IBD units (58.4% vs. 39.7%) and multidisciplinary meetings (73.2% vs. 40.1%), were observed between respondees from high and low GDP countries (p < 0.0001). In high GDP countries, IBD nurses are more common (85.9% vs. 36.0%), also mirrored by more nurse-led IBD clinics (40.6% vs. 13.7%; p < 0.0001). IBD dieticians (33.4% vs. 16.5%) and psychologists (16.8% vs. 7.5%) are mainly present in high GDP countries (p < 0.0001). In the current COVID era, telemedicine is available in 73.2% versus 54.1% of the high/low GDP countries, respectively (p < 0.0001). Treat-to-target approaches are implemented everywhere (85.0%), though access to biologicals and small molecules differs significantly.CONCLUSION: Much variability in IBD practice exists across Europe, with marked differences between high and low GDP countries. Further work is required to help address some of these inequalities, aiming to improve and standardize IBD care and training across Europe.
UR - http://www.scopus.com/inward/record.url?scp=85152674936&partnerID=8YFLogxK
U2 - 10.1159/000528070
DO - 10.1159/000528070
M3 - Journal article
C2 - 36412565
AN - SCOPUS:85152674936
SN - 0257-2753
VL - 41
SP - 387
EP - 395
JO - Digestive Diseases
JF - Digestive Diseases
IS - 3
ER -